AudiologyOnline Phone: 800-753-2160


Neuromod Devices - Your Partner for Tinnitus - September 2021

Contact Information

Neuromod Devices Ltd.
Neuromod USA, 700 Commerce Drive
Suite 500
Oakbrook, IL 60523
Website: neuromoddevices.com
Email: InfoUS@neuromoddevices.com

Neuromod Devices Ltd.

Stimulating Possibilities


Read More

News

Real World Data Supports Lenire Tinnitus Treatment Effectiveness Shown in Large-Scale Clinical Trials

Neuromod Partners with 14 New US Tinnitus Clinics to Expand Availability of FDA Approved Lenire

FDA-Approved Lenire Tinnitus Device Now a Treatment Option for 2.9 Million US Veterans Through Veterans Affairs

Breakthrough Tinnitus Treatment Device Lenire Expands Clinics in Spain

FDA Approved Lenire Expands Number of US Clinics

Lenire Now Available in Monaco Through Otoneuro

Neuromod Expands Lenire’s US Availability to More Than 50 Providers

Neuromod Devices Closes €30 Million Financing to Expand Availability of Tinnitus Treatment Device Lenire®

FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms

Lenire®, the Treatment Device Shown to Reduce Tinnitus Symptoms in 86.2% Of Patients, Is Now Available in Norway

Neuromod Establishes Global Commercial Leadership Team

Resources

Clinical Experience with Lenire - Case Report of a Patient with Catastrophic Symptom Severity

This real world case study details how Lenire helped a catastrophic tinnitus patient lower their THI score from 94 to 27.

Clinical Experience with Lenire®- Case Report of a Patient whose Vestibular Symptoms Improved

This real world case study details how a patient with tinnitus and vestibular condition lowered his tinnitus from 55 THI to 16 THI. As an unexpected side benefit, this patient also gained improved balance.

Psychotherapy Case Study of Patient attending Tinnitus Therapy (Otologie – Dublin)

A combination of cognitive behaviour therapy and Lenire helped a real-world patient lower their THI score from 66 to 14.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.